Guardian Program

About Vesiflo

Vesiflo is a private, commercial-stage medical device company addressing a significant unmet need in female urology: chronic urinary retention. Its core product, the inFlow device, is an FDA-cleared, disposable intraurethral valve-pump that offers an alternative to intermittent self-catheterization, aiming to improve quality of life and reduce urinary tract infections. The company is augmenting its hardware with a digital health initiative, the Guardian Program, to enable remote patient monitoring and create a clinical data ecosystem. Operating from Massachusetts, Vesiflo targets a substantial patient population that has historically had limited treatment options.

Therapeutic Areas